DrugPatentWatch Database Preview
R - Profile
US Patents for r
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals | LIBTAYO | cemiplimab-rwlc | INJECTABLE;INTRAVENOUS | 761097 | 001 | 2019-03-20 | RX | |||||
Regeneron Pharmaceuticals | DUPIXENT | dupilumab | INJECTABLE; INJECTION | 761055 | 001 | 2017-03-28 | 9,763,918 | Knopp Biosciences LLC (Pittsburgh, PA) | 2033-08-13 | RX | search | |
Regeneron Pharmaceuticals | DUPIXENT | dupilumab | INJECTABLE; INJECTION | 761055 | 001 | 2017-03-28 | 9,290,574 | Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) | 2033-07-11 | RX | search | |
Regeneron Pharmaceuticals | DUPIXENT | dupilumab | INJECTABLE; INJECTION | 761055 | 001 | 2017-03-28 | 10,485,844 | Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) Sanofi Biotechnology (Paris, FR) | 2037-08-18 | RX | search | |
Regeneron Pharmaceuticals | DUPIXENT | dupilumab | INJECTABLE; INJECTION | 761055 | 001 | 2017-03-28 | 10,456,381 | Knopp Biosciences LLC (Pittsburgh, PA) | 2033-08-13 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |